Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
Sponsor: Latigo Biotherapeutics
Summary
The goal of this clinical trial is to learn if LTG-001 works to treat post-operative / acute pain after an abdominoplasty procedure. It will also learn more information on the safety of LTG-001. The main questions it aims to answer are: Does drug LTG-001 treat the acute pain after surgical abdominoplasty over 48 hours? How tolerable is LTG-001 over 48 hours? What dose of LTG-001 is better for treating post-operative / acute pain? Participants will: Take LTG-001 bid after the surgical abdominoplasty. Remain at the clinic for approximately 48 hours during study dosing and return after two weeks for a safety check up. Report the pain relief during the 48 hours to record changes in the post-operative pain.
Official title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After an Abdominoplasty
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
343
Start Date
2025-07-24
Completion Date
2026-01-07
Last Updated
2026-04-29
Healthy Volunteers
No
Conditions
Interventions
Experimental: LTG-001 High Dose
High Dose Active
Experimental: LTG-001 Low Dose
Lower Dose Active
Active Comparator: HB/APAP
Active Comparator
Placebo Comparator
Placebo
Locations (5)
Arizona Research Center
Phoenix, Arizona, United States
CenExel ACMR
Atlanta, Georgia, United States
HD Research LLC
Houston, Texas, United States
Endeavor Clinical Research
San Antonio, Texas, United States
JBR Clinical Research (CenExel)
Salt Lake City, Utah, United States